Pre-Exposure Prophylaxis (PrEP): What Anesthesia Providers Need to Know About This Important HIV Prevention Tool (1 Class A CE with 1 Pharm)

Pre-Exposure Prophylaxis (PrEP) is the highly effective use of antiretroviral medications by people without HIV to protect themselves from getting HIV. CDC estimates that 1.2 million people could benefit from PrEP in the United States. However, there is a significant gap in the literature and practice guidelines regarding anesthesia considerations for patients utilizing PrEP medications.
This presentation will address the anesthesia providers gap in knowledge regarding this important HIV prevention tool. The content of this lecture will include 3 major topics: 1) The current state of HIV and HIV Prevention in the US, including the high risk populations and barriers to treatment, 2) An introduction to Pre-exposure Prophylaxis (PrEP) including the indications and types of PrEP, and 3) an overview of the Implications for anesthesia providers including medication interactions , effects of the PrEP on the body, and anesthetic implications of PrEP medications.

Class A credit can only be earned for participation in synchronous learning via live in-person or live webinar sessions. In-person attendees can only receive Class A credit for the sessions they attend live.

Due to CE guidelines, sessions which are recorded will not be available for viewing immediately following Congress.